About us
UNIXIS AG offers tailored solutions in the cannabis sector that ensure your market success – from product development and sourcing to manufacturing, packaging, and successful market entry.
Articles
UNIXIS AG is part of the Siegfried Pharma Park and holds the following licenses issued by Swissmedic.
Pharmaceutical operating license (GDP)
From flower to finished product
Together with our partner, Siegfried AG (www.siegfried.ch), we are conducting a Swissmedic-approved pilot project for the production of THC distillate (cGMP) for the pharmaceutical sector. This extract, which can also be used for clinical trials in humans, along with the regulatory supporting documents, will form the basis for the commercialization phase, allowing us to scale up production to larger quantities.
Success through established process management
To ensure faster decision-making, flexibility, and the necessary expertise in the right places, technical and commercial project management at UNIXIS AG are kept separate.
This ensures that the demanding customer requirements are always met while adhering to high-quality standards and within an appropriate timeframe.
Licensed international trade
In addition to the achievements in research and development, which culminate in the aforementioned pilot project, UNIXIS AG has successfully imported THC flowers for resale.
As a licensed company, we are able to import and/or export quantities in the ton range.
The quality assurance of the material is ensured through our regulatory requirements for sampling and inspection.
